Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (75N92020C00008, 75N92020C00021)
- License Information
-
More Information
Article History
Received: 5 September 2022
Revised: 5 September 2022
Accepted: 3 October 2022
First Online: 2 November 2022
Declarations
:
: This study involves human subjects and was approved by Stanford University and University of Pennsylvania IRBs. The IRBs determined that no consent was necessary.
: Personal financial interests: Board of directors and shareholder, Bunkerhill Health; Option holder, whiterabbit.ai; Advisor and option holder, GalileoCDS; Advisor and option holder, Sirona Medical; Advisor and option holder, Adra; Advisor and option holder, Kheiron; Advisor, Sixth Street; Chair, SIIM Board of Directors; Member at Large, Board of Directors of the Pennsylvania Radiological Society; Member at Large, Board of Directors of the Philadelphia Roentgen Ray Society; Member at Large, Board of Directors of the Association of University Radiologists (term just ended in June); Honoraria, Sectra (webinars); Honoraria, British Journal of Radiology (section editor); Speaker honorarium, Icahn School of Medicine (conference speaker); Speaker honorarium, MGH (conference speaker). Recent grant and gift support paid to academic institutions involved: Carestream; Clairity; GE Healthcare; Google Cloud; IBM; IDEXX; Hospital Israelita Albert Einstein; Kheiron; Lambda; Lunit; Microsoft; Nightingale Open Science; Nines; Philips; Subtle Medical; VinBrain; Whiterabbit.ai; Lowenstein Foundation; Gordon and Betty Moore Foundation; Paustenbach Fund. Grant funding: NIH; Independence Blue Cross; RSNA.
Free to read: This content has been made available to all.
